The crystal structure of human cathepsin L complexed with E-64
- PMID: 9141479
- DOI: 10.1016/s0014-5793(97)00216-0
The crystal structure of human cathepsin L complexed with E-64
Abstract
We have determined the three dimensional structure of the complex of human cathepsin L and E-64, an irreversible inhibitor of cysteine proteases, at 2.5 A resolution. The overall structure was similar to that of other known cysteine proteases and apparently identical to the mature region of procathepsin L. The electron density for E-64 is clearly visible except for the guanidinobutane moiety. From comparison of the active sites of cathepsin L and B, we found the following: (1) The S' subsites of cathepsin L and B are totally different because of the 'occluding loop' lying on the end of the S' subsites of cathepsin B. (2) The S2 pocket of cathepsin L is shallow and narrow compared to that of cathepsin B. (3) The S3 subsites of the two enzymes are more similar than the other subsites, but cathepsin L may accommodate a more bulky group at this site. Knowledge of the active site structure of cathepsin L should be helpful for the structure-based design of potent and specific inhibitors which are of therapeutic importance.
Similar articles
-
Exploring inhibitor binding at the S' subsites of cathepsin L.J Med Chem. 2008 Mar 13;51(5):1361-8. doi: 10.1021/jm701190v. Epub 2008 Feb 16. J Med Chem. 2008. PMID: 18278855
-
Crystal structure of human cathepsin V.Biochemistry. 2000 Oct 17;39(41):12543-51. doi: 10.1021/bi000951p. Biochemistry. 2000. PMID: 11027133
-
Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.Biopolymers. 1999;51(1):99-107. doi: 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R. Biopolymers. 1999. PMID: 10380357
-
The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.Chembiochem. 2006 Oct;7(10):1525-35. doi: 10.1002/cbic.200600149. Chembiochem. 2006. PMID: 16921579 Review.
-
Papain-like lysosomal cysteine proteases and their inhibitors: drug discovery _targets?Biochem Soc Symp. 2003;(70):15-30. doi: 10.1042/bss0700015. Biochem Soc Symp. 2003. PMID: 14587279 Review.
Cited by
-
Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy.Anticancer Agents Med Chem. 2024;24(16):1167-1181. doi: 10.2174/0118715206303964240708095110. Anticancer Agents Med Chem. 2024. PMID: 38988167 Review.
-
Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.Biochem J. 2000 Apr 1;347 Pt 1(Pt 1):123-9. Biochem J. 2000. PMID: 10727410 Free PMC article.
-
Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.Annu Rev Pharmacol Toxicol. 2008;48:393-423. doi: 10.1146/annurev.pharmtox.48.113006.094812. Annu Rev Pharmacol Toxicol. 2008. PMID: 18184105 Free PMC article. Review.
-
Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L.Mol Pharmacol. 2008 Jul;74(1):34-41. doi: 10.1124/mol.108.046219. Epub 2008 Apr 10. Mol Pharmacol. 2008. PMID: 18403718 Free PMC article.
-
Affinity-Enhanced Luminescent Re(I)- and Ru(II)-Based Inhibitors of the Cysteine Protease Cathepsin L.Inorg Chem. 2018 Jul 2;57(13):7881-7891. doi: 10.1021/acs.inorgchem.8b00978. Epub 2018 Jun 8. Inorg Chem. 2018. PMID: 29882662 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
